MMedication Read More Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even BetterJune 4, 2026 Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
MMedication Read More Pharmacy ordered to recall unregistered weight-loss medicines after raidMay 25, 2026 THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a…